Xiangling Xiao

机构：Hebei General Hospital · ORCID：0000-0002-5352-3441

发表论文 23 篇 · 总被引 935 次 · h-index 15

代表论文

• USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy (2022 · Nature Communications · 被引 160)
• USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy (2024 · Proceedings of the National Academy of Sciences · 被引 135)
• Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy (2023 · Cell chemical biology · 被引 98)
• ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy (2023 · Nature Communications · 被引 87)
• PD-1 regulation in immune homeostasis and immunotherapy (2024 · Cancer Letters · 被引 74)
• UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity (2024 · Molecular Cell · 被引 70)